As filed with the Securities and Exchange Commission on June 19, 2000
                                                     Registration No. 333-______


                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                              ____________________

                                    FORM S-8
             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                              ____________________

                              POSSIS MEDICAL, INC.
             (Exact name of registrant as specified in its charter)

          Minnesota                                       41-0783184
(State or other jurisdiction                           (I.R.S. Employer
      of incorporation)                               Identification No.)
           9055 Evergreen Boulevard N.W. Minneapolis, Minnesota 55433
               (Address of principal executive offices) (Zip Code)


                POSSIS MEDICAL, INC. 1999 STOCK COMPENSATION PLAN
                            (Full title of the plan)

        Irving R. Colacci                                Copy to:
  Vice President, Legal Affairs                     Amy E. Ayotte, Esq.
& Human Resources, General Counsel                  Dorsey & Whitney LLP
         and Secretary                             Pillsbury Center South
      Possis Medical, Inc.                         220 South Sixth Street
  9055 Evergreen Boulevard N.W.               Minneapolis, Minnesota 55402-1498
  Minneapolis, Minnesota  55433                            (612) 340-6323
        (763) 780-4555
 (Name, address and telephone number, including area code, of agent for service)
                              ____________________

                         CALCULATION OF REGISTRATION FEE

===============================================================================
                                  Proposed          Proposed
  Title of        Amount           Maximum           Maximum         Amount of
Securities to      to be        Offering Price      Aggregate       Registration
be Registered   Registered (1)   Per Share (2)  Offering Price (2)      Fee

===============================================================================
===============================================================================
Common Stock,
$.40 par value    2,000,000        $6.75          $13,500,000          $3,564
===============================================================================

     (1) Estimated solely for the purpose of calculating the registration fee in
accordance  with Rule  457(c) and  457(h)(1).  The  proposed  maximum  aggregate
offering  price is based  upon the  average  of the high and low  prices  of the
Common  Stock as reported on the Nasdaq  consolidated  reporting  system on June
15, 2000.

<PAGE>

                                      II-3
                                    PART II.
               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference.

     The following documents that we have filed with the Securities and Exchange
Commission are incorporated by reference into this registration statement:

     o our annual report on Form 10-K for the fiscal year ended July 31, 1999;

     o our  quarterly  reports on Form 10-Q for the quarters  ended  October 31,
1999, January 31, 2000 and April 30, 2000;

     o our current report on Form 8-K filed on March 14, 2000; and

     o the description of our common stock contained in any of our  registration
statements filed under the Securities Exchange Act of 1934, as amended,  and any
amendment or report filed for the purpose of updating the description.

     All documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of
the Exchange Act subsequent to the date of this registration statement and prior
to the  filing of a  post-effective  amendment  indicating  that all  securities
offered by this  registration  statement  have been sold, or  deregistering  all
securities  remaining unsold, shall be deemed to be incorporated by reference in
this registration statement and to be a part of this registration statement from
the respective  dates of filing of such  documents.  Any statement  contained in
this  registration  statement  or  in  a  document  all  or  part  of  which  is
incorporated  or deemed to be  incorporated  by reference  in this  registration
statement  shall be deemed to be modified  or  superseded  for  purposes of this
registration  statement  to  the  extent  that a  statement  contained  in  this
registration  statement or in any subsequently filed document that also is or is
deemed to be incorporated by reference in this registration  statement  modifies
or supersedes such statement. Any such statement so modified or superseded shall
not be deemed, except as so modified or superseded, to constitute a part of this
registration statement.

Item 4.  Description of Securities.

         Not applicable.

Item 5.  Interests of Named Experts and Counsel.

         Not applicable.

Item 6.  Indemnification of Directors and Officers.

     Section  302A.521  of  the  Minnesota  Business  Corporation  Act  requires
corporations  to  indemnify  any person who is made or  threatened  to be made a
party to any proceeding,  by reason of the person's  former or present  official
capacity,  against  judgments,  penalties,  fines,  settlements  and  reasonable
expenses, including attorneys' fees and disbursements, incurred by the person in
connection  with  the  proceeding  if  certain  statutory   standards  are  met.
"Proceeding"  means  a  threatened,   pending  or  completed  civil,   criminal,
administrative,  arbitration or investigative proceeding, including one by or in
the right of the  corporation.  The  general  effect of Section  302A.521  is to
reimburse  (or pay on behalf of) the  directors  and officers of Possis  Medical
with  respect to any  personal  liability  that may be imposed for certain  acts
performed in their  capacity as our directors  and  officers,  except where they
have not acted in good faith. Section 302A.521 contains detailed terms regarding
this right of  indemnification,  and reference is made to Section 302A.521 for a
complete statement of indemnification rights.

     Our bylaws provide for  indemnification  to the maximum extent permitted by
Minnesota   Statutes.   In   addition,   the  Company   generally   enters  into
indemnification  agreements with our officers and directors,  and we maintain an
insurance policy to assist in funding  indemnification of directors and officers
for certain liabilities.

<PAGE>

Item 7.  Exemption from Registration Claimed.

         Not applicable.

Item 8.  Exhibits.

     4.1 Possis Medical,  Inc. 1999 Stock  Compensation  Plan  (incorporated  by
reference to the  registrant's  Definitive  Proxy  Statement  filed  November 8,
1999).

     5.1 Opinion of Dorsey & Whitney LLP.

     23.1 Consent of Deloitte & Touche LLP.

     23.2 Consent of Dorsey & Whitney LLP (included in Exhibit 5.1).

Item 9.  Undertakings.

     (a) The undersigned registrant hereby undertakes:

     (1) To file,  during any period in which  offers or sales are being made, a
post-effective amendment to this registration statement:

     (i)  To  include  any  prospectus  required  by  Section  10(a)(3)  of  the
Securities Act of 1933;

     (ii) To reflect in the  prospectus  any facts or events  arising  after the
effective date of the registration  statement (or the most recent post-effective
amendment  thereof)  which,  individually  or  in  the  aggregate,  represent  a
fundamental  change in the information set forth in the registration  statement.
Notwithstanding the foregoing,  any increase or decrease in volume of securities
offered (if the total dollar value of securities would not exceed that which was
registered) and any deviation from the low or high end of the estimated  maximum
offering  range  may be  reflected  in the  form of  prospectus  filed  with the
Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate,
the  changes  in volume  and price  represent  no more than a 20%  change in the
maximum  aggregate  offering price set forth in the "Calculation of Registration
Fee" table in the effective registration statement; and

     (iii) To  include  any  material  information  with  respect to the plan of
distribution  not  previously  disclosed  in the  registration  statement or any
material change to such information in the registration statement;

     Provided,  however, that paragraphs (a)(1)(i) and (a)(1)(ii) above will not
apply if the  registration  statement is on Form S-3,  Form S-8 or Form F-3, and
the information  required to be included in a post-effective  amendment by those
paragraphs  is  contained  in periodic  reports  filed with or  furnished to the
Commission  by the  registrant  pursuant  to Section 13 or Section  15(d) of the
Securities  Exchange  Act of 1934  that are  incorporated  by  reference  in the
registration statement.

     (2) That, for the purpose of determining any liability under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

     (3) To remove from registration by means of a post-effective  amendment any
of the securities being registered which remain unsold at the termination of the
offering.

<PAGE>

     (b) The  undersigned  registrant  hereby  undertakes  that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Securities  Exchange  Act of 1934  (and,  where  applicable,  each  filing of an
employee  benefit  plan's  annual  report  pursuant  to  section  15(d)  of  the
Securities  Exchange  Act of 1934)  that is  incorporated  by  reference  in the
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

     (c) Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the  registrant  pursuant  to  the  foregoing  provisions,   or  otherwise,  the
registrant  has been advised that in the opinion of the  Securities and Exchange
Commission  such  indemnification  is against  public policy as expressed in the
Securities Act and is, therefore,  unenforceable.  In the event that a claim for
indemnification  against  such  liabilities  (other  than  the  payment  by  the
registrant  of  expenses  incurred  or  paid by a  director,  officer  or  other
controlling  person of the registrant in the  successful  defense of any action,
suit or proceeding) is asserted by such director,  officer or controlling person
in connection with the securities being registered,  the registrant will, unless
in the  opinion  of its  counsel  the matter  has been  settled  by  controlling
precedent,  submit to a court of appropriate  jurisdiction  the question whether
such  indemnification  by it is  against  public  policy  as  expressed  in  the
Securities Act and will be governed by the final adjudication of such issue.

<PAGE>

                                   SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  registration
statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in the City of Minneapolis, State of Minnesota, on June 19, 2000.

                                      POSSIS MEDICAL, INC.

                                      /s/ Robert G. Dutcher

                                      Robert G. Dutcher
                                      President and Chief Executive Officer

     KNOW ALL  PERSONS  BY THESE  PRESENTS,  that each  person  whose  signature
appears  below  hereby  constitutes  and  appoints  Robert G. Dutcher and Irving
Colacci,  and each of them, the undersigned's true and lawful  attorneys-in-fact
and  agents,  with  full  power  of  substitution  and  resubstitution,  for the
undersigned  and in his or her name,  place and stead, in any and all capacities
(including  the  undersigned's  capacity as a director  and/or officer of Possis
Medical,  Inc.), to sign a registration statement on Form S-8 of Possis Medical,
Inc. to be filed under the  Securities Act of 1933 for the  registration  of the
sale or issuance from time to time of up to 2,000,000  shares of common stock of
Possis Medical issuable under the 1999 Stock  Compensation  Plan and any and all
amendments (including post-effective amendments) to such registration statement,
and to file  the  same,  with all  exhibits  thereto,  and  other  documents  in
connection therewith, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact and agents, and each of them, full power and authority to
do and perform each and every act and thing  requisite  and necessary to be done
in about the premises,  as fully to all intents and purposes as the  undersigned
might or could do in  person,  hereby  ratifying  and  confirming  all that said
attorneys-in-fact and agents or any of them, or their substitutes,  may lawfully
do or cause to be done by virtue hereof.

     Pursuant  to  the   requirements  of  the  Securities  Act  of  1933,  this
registration  statement  has  been  signed  by  the  following  persons  in  the
capacities and on the date indicated.

      Name                             Title                          Date

/s/ Robert G. Dutcher     President, Chief Executive Officer     June 19, 2000
Robert G. Dutcher         and Director (principal executive
                          officer and principal financial and
                          accounting officer)

/s/ Donald C. Wegmiller   Chairman of the Board                  June 19, 2000
Donald C. Wegmiller


/s/ Dean Belbas           Director                               June 19, 2000
Dean Belbas


/s/ Seymour J. Mansfield  Director                               June 19, 2000
Seymour J. Mansfield


/s/ William C. Mattison   Director                               June 19, 2000
William C. Mattison


/s/ Whitney A. McFarlin   Director                               June 19, 2000
Whitney A. McFarlin


/s/ Rodney A. Young       Director                               June 19, 2000
Rodney A. Young

<PAGE>

                                  EXHIBIT INDEX

     4.1 Possis Medical,  Inc. 1999 Stock  Compensation  Plan  (incorporated  by
reference to the  registrant's  Definitive  Proxy  Statement  filed  November 8,
1999).

     5.1 Opinion of Dorsey & Whitney LLP.

     23.1 Consent of Deloitte & Touche LLP.

     23.2 Consent of Dorsey & Whitney LLP (included in Exhibit 5.1).

<PAGE>

                                                                    EXHIBIT 5.1

                      [Letterhead of Dorsey & Whitney LLP]


Possis Medical, Inc.
9055 Evergreen Boulevard N.W.
Minneapolis, Minnesota 55433

         Re:      Registration Statement on Form S-8

Ladies and Gentlemen:

     We have acted as counsel to Possis Medical,  Inc., a Minnesota  corporation
(the "Company"),  and have advised the Company in connection with a registration
statement  on Form S-8 relating to the sale or issuance by the Company from time
to time of up to  2,000,000  shares (the  "Shares") of common  stock,  par value
$.40, of the Company ("Common Stock") issuable under the 1999 Stock Compensation
Plan (the "Plan").

     We have examined such  documents and have reviewed such questions of law as
we have considered necessary and appropriate for the purposes of our opinion set
forth below.

     In rendering our opinion set forth below, we have assumed the  authenticity
of all documents submitted to us as originals, the genuineness of all signatures
and the  conformity to authentic  originals of all documents  submitted to us as
copies. We have also assumed the legal capacity for all purposes relevant hereto
of all  natural  persons  and,  with  respect to all  parties to  agreements  or
instruments  relevant  hereto other than the Company,  that such parties had the
requisite power and authority  (corporate or otherwise) to execute,  deliver and
perform such agreements or instruments, that such agreements or instruments have
been duly authorized by all requisite action (corporate or otherwise),  executed
and delivered by such parties and that such  agreements or  instruments  are the
valid,  binding and enforceable  obligations of such parties. As to questions of
fact material to our opinion,  we have relied upon  certificates  of officers of
the Company and of public officials.

     Based on the  foregoing,  we are of the  opinion  that the Shares have been
duly authorized and, upon issuance,  delivery and payment therefor in accordance
with the terms of the Plan,  and any  relevant  agreements  thereunder,  will be
validly issued, fully paid and nonassessable.

     Our  opinions  expressed  above  are  limited  to the laws of the  State of
Minnesota.

     We hereby  consent  to the  filing of this  opinion  as an  exhibit  to the
registration statement on Form S-8 of the Company relating to the Shares.

Dated:  June 19, 2000

                                           Very truly yours,

                                           /s/ Dorsey & Whitney LLP

<PAGE>

                                                                   EXHIBIT 23.1




INDEPENDENT AUDITORS' CONSENT

     We consent to the incorporation by reference in this Registration Statement
of  Possis  Medical,  Inc.  on Form S-8 of our  report  dated  August  31,  1999
(September 15, 1999 as to Note 10),  appearing in the Annual Report on Form 10-K
of Possis Medical, Inc. for the year ended July 31, 1999.

/s/ Deloitte & Touche LLP

Minneapolis, Minnesota
June 19, 2000
[{"type": "S-8", "sequence": "1", "filename": "0001.txt", "description": "FORM S-8 REGISTRATION STATEMENT", "secsgml_size_bytes": 18413}]
{"company-data": {"conformed-name": "POSSIS MEDICAL INC", "cik": "0000079677", "assigned-sic": "3842", "irs-number": "410783184", "state-of-incorporation": "MN", "fiscal-year-end": "0731"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-39726", "film-number": "657860"}, "business-address": {"street1": "9055 EVERGREEN BLVD N W", "city": "MINNEAPOLIS", "state": "MN", "zip": "55433-8003", "phone": "6127804555"}, "mail-address": {"street1": "9055 EVERGREEN BLVD N W", "city": "MINNAPOLIS", "state": "MN", "zip": "55433-8003"}, "former-company": {"former-conformed-name": "POSSIS MACHINE CORP", "date-changed": "19721106"}}
As filed with the Securities and Exchange Commission on June 19, 2000
                                                     Registration No. 333-______

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                              ____________________

                                    FORM S-8
             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                              ____________________

                              POSSIS MEDICAL, INC.
             (Exact name of registrant as specified in its charter)

          Minnesota                                       41-0783184
(State or other jurisdiction                           (I.R.S. Employer
      of incorporation)                               Identification No.)
           9055 Evergreen Boulevard N.W. Minneapolis, Minnesota 55433
               (Address of principal executive offices) (Zip Code)

                POSSIS MEDICAL, INC. 1999 STOCK COMPENSATION PLAN
                            (Full title of the plan)

        Irving R. Colacci                                Copy to:
  Vice President, Legal Affairs                     Amy E. Ayotte, Esq.
& Human Resources, General Counsel                  Dorsey & Whitney LLP
         and Secretary                             Pillsbury Center South
      Possis Medical, Inc.                         220 South Sixth Street
  9055 Evergreen Boulevard N.W.               Minneapolis, Minnesota 55402-1498
  Minneapolis, Minnesota  55433                            (612) 340-6323
        (763) 780-4555
 (Name, address and telephone number, including area code, of agent for service)
                              ____________________

                         CALCULATION OF REGISTRATION FEE

===============================================================================
                                  Proposed          Proposed
  Title of        Amount           Maximum           Maximum         Amount of
Securities to      to be        Offering Price      Aggregate       Registration
be Registered   Registered (1)   Per Share (2)  Offering Price (2)      Fee

===============================================================================
===============================================================================
Common Stock,
$.40 par value    2,000,000        $6.75          $13,500,000          $3,564
===============================================================================

     (1) Estimated solely for the purpose of calculating the registration fee in
accordance  with Rule  457(c) and  457(h)(1).  The  proposed  maximum  aggregate
offering  price is based  upon the  average  of the high and low  prices  of the
Common  Stock as reported on the Nasdaq  consolidated  reporting  system on June
15, 2000.
II-3
                                    PART II.
               INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference.

     The following documents that we have filed with the Securities and Exchange
Commission are incorporated by reference into this registration statement:

     o our annual report on Form 10-K for the fiscal year ended July 31, 1999;

     o our  quarterly  reports on Form 10-Q for the quarters  ended  October 31,
1999, January 31, 2000 and April 30, 2000;

     o our current report on Form 8-K filed on March 14, 2000; and

     o the description of our common stock contained in any of our  registration
statements filed under the Securities Exchange Act of 1934, as amended,  and any
amendment or report filed for the purpose of updating the description.

     All documents filed by us pursuant to Sections 13(a), 13(c), 14 or 15(d) of
the Exchange Act subsequent to the date of this registration statement and prior
to the  filing of a  post-effective  amendment  indicating  that all  securities
offered by this  registration  statement  have been sold, or  deregistering  all
securities  remaining unsold, shall be deemed to be incorporated by reference in
this registration statement and to be a part of this registration statement from
the respective  dates of filing of such  documents.  Any statement  contained in
this  registration  statement  or  in  a  document  all  or  part  of  which  is
incorporated  or deemed to be  incorporated  by reference  in this  registration
statement  shall be deemed to be modified  or  superseded  for  purposes of this
registration  statement  to  the  extent  that a  statement  contained  in  this
registration  statement or in any subsequently filed document that also is or is
deemed to be incorporated by reference in this registration  statement  modifies
or supersedes such statement. Any such statement so modified or superseded shall
not be deemed, except as so modified or superseded, to constitute a part of this
registration statement.

Item 4.  Description of Securities.

         Not applicable.

Item 5.  Interests of Named Experts and Counsel.

         Not applicable.

Item 6.  Indemnification of Directors and Officers.

     Section  302A.521  of  the  Minnesota  Business  Corporation  Act  requires
corporations  to  indemnify  any person who is made or  threatened  to be made a
party to any proceeding,  by reason of the person's  former or present  official
capacity,  against  judgments,  penalties,  fines,  settlements  and  reasonable
expenses, including attorneys' fees and disbursements, incurred by the person in
connection  with  the  proceeding  if  certain  statutory   standards  are  met.
"Proceeding"  means  a  threatened,   pending  or  completed  civil,   criminal,
administrative,  arbitration or investigative proceeding, including one by or in
the right of the  corporation.  The  general  effect of Section  302A.521  is to
reimburse  (or pay on behalf of) the  directors  and officers of Possis  Medical
with  respect to any  personal  liability  that may be imposed for certain  acts
performed in their  capacity as our directors  and  officers,  except where they
have not acted in good faith. Section 302A.521 contains detailed terms regarding
this right of  indemnification,  and reference is made to Section 302A.521 for a
complete statement of indemnification rights.

     Our bylaws provide for  indemnification  to the maximum extent permitted by
Minnesota   Statutes.   In   addition,   the  Company   generally   enters  into
indemnification  agreements with our officers and directors,  and we maintain an
insurance policy to assist in funding  indemnification of directors and officers
for certain liabilities.
Item 7.  Exemption from Registration Claimed.

         Not applicable.

Item 8.  Exhibits.

     4.1 Possis Medical,  Inc. 1999 Stock  Compensation  Plan  (incorporated  by
reference to the  registrant's  Definitive  Proxy  Statement  filed  November 8,
1999).

     5.1 Opinion of Dorsey & Whitney LLP.

     23.1 Consent of Deloitte & Touche LLP.

     23.2 Consent of Dorsey & Whitney LLP (included in Exhibit 5.1).

Item 9.  Undertakings.

     (a) The undersigned registrant hereby undertakes:

     (1) To file,  during any period in which  offers or sales are being made, a
post-effective amendment to this registration statement:

     (i)  To  include  any  prospectus  required  by  Section  10(a)(3)  of  the
Securities Act of 1933;

     (ii) To reflect in the  prospectus  any facts or events  arising  after the
effective date of the registration  statement (or the most recent post-effective
amendment  thereof)  which,  individually  or  in  the  aggregate,  represent  a
fundamental  change in the information set forth in the registration  statement.
Notwithstanding the foregoing,  any increase or decrease in volume of securities
offered (if the total dollar value of securities would not exceed that which was
registered) and any deviation from the low or high end of the estimated  maximum
offering  range  may be  reflected  in the  form of  prospectus  filed  with the
Securities and Exchange Commission pursuant to Rule 424(b) if, in the aggregate,
the  changes  in volume  and price  represent  no more than a 20%  change in the
maximum  aggregate  offering price set forth in the "Calculation of Registration
Fee" table in the effective registration statement; and

     (iii) To  include  any  material  information  with  respect to the plan of
distribution  not  previously  disclosed  in the  registration  statement or any
material change to such information in the registration statement;

     Provided,  however, that paragraphs (a)(1)(i) and (a)(1)(ii) above will not
apply if the  registration  statement is on Form S-3,  Form S-8 or Form F-3, and
the information  required to be included in a post-effective  amendment by those
paragraphs  is  contained  in periodic  reports  filed with or  furnished to the
Commission  by the  registrant  pursuant  to Section 13 or Section  15(d) of the
Securities  Exchange  Act of 1934  that are  incorporated  by  reference  in the
registration statement.

     (2) That, for the purpose of determining any liability under the Securities
Act of 1933,  each  such  post-effective  amendment  shall be deemed to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

     (3) To remove from registration by means of a post-effective  amendment any
of the securities being registered which remain unsold at the termination of the
offering.
(b) The  undersigned  registrant  hereby  undertakes  that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Securities  Exchange  Act of 1934  (and,  where  applicable,  each  filing of an
employee  benefit  plan's  annual  report  pursuant  to  section  15(d)  of  the
Securities  Exchange  Act of 1934)  that is  incorporated  by  reference  in the
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

     (c) Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the  registrant  pursuant  to  the  foregoing  provisions,   or  otherwise,  the
registrant  has been advised that in the opinion of the  Securities and Exchange
Commission  such  indemnification  is against  public policy as expressed in the
Securities Act and is, therefore,  unenforceable.  In the event that a claim for
indemnification  against  such  liabilities  (other  than  the  payment  by  the
registrant  of  expenses  incurred  or  paid by a  director,  officer  or  other
controlling  person of the registrant in the  successful  defense of any action,
suit or proceeding) is asserted by such director,  officer or controlling person
in connection with the securities being registered,  the registrant will, unless
in the  opinion  of its  counsel  the matter  has been  settled  by  controlling
precedent,  submit to a court of appropriate  jurisdiction  the question whether
such  indemnification  by it is  against  public  policy  as  expressed  in  the
Securities Act and will be governed by the final adjudication of such issue.
SIGNATURES

     Pursuant to the  requirements of the Securities Act of 1933, the registrant
certifies  that it has  reasonable  grounds to believe  that it meets all of the
requirements  for  filing  on Form S-8 and has  duly  caused  this  registration
statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized, in the City of Minneapolis, State of Minnesota, on June 19, 2000.

                                      POSSIS MEDICAL, INC.

                                      /s/ Robert G. Dutcher

                                      Robert G. Dutcher
                                      President and Chief Executive Officer

     KNOW ALL  PERSONS  BY THESE  PRESENTS,  that each  person  whose  signature
appears  below  hereby  constitutes  and  appoints  Robert G. Dutcher and Irving
Colacci,  and each of them, the undersigned's true and lawful  attorneys-in-fact
and  agents,  with  full  power  of  substitution  and  resubstitution,  for the
undersigned  and in his or her name,  place and stead, in any and all capacities
(including  the  undersigned's  capacity as a director  and/or officer of Possis
Medical,  Inc.), to sign a registration statement on Form S-8 of Possis Medical,
Inc. to be filed under the  Securities Act of 1933 for the  registration  of the
sale or issuance from time to time of up to 2,000,000  shares of common stock of
Possis Medical issuable under the 1999 Stock  Compensation  Plan and any and all
amendments (including post-effective amendments) to such registration statement,
and to file  the  same,  with all  exhibits  thereto,  and  other  documents  in
connection therewith, with the Securities and Exchange Commission, granting unto
said attorneys-in-fact and agents, and each of them, full power and authority to
do and perform each and every act and thing  requisite  and necessary to be done
in about the premises,  as fully to all intents and purposes as the  undersigned
might or could do in  person,  hereby  ratifying  and  confirming  all that said
attorneys-in-fact and agents or any of them, or their substitutes,  may lawfully
do or cause to be done by virtue hereof.

     Pursuant  to  the   requirements  of  the  Securities  Act  of  1933,  this
registration  statement  has  been  signed  by  the  following  persons  in  the
capacities and on the date indicated.

      Name                             Title                          Date

/s/ Robert G. Dutcher     President, Chief Executive Officer     June 19, 2000
Robert G. Dutcher         and Director (principal executive
                          officer and principal financial and
                          accounting officer)

/s/ Donald C. Wegmiller   Chairman of the Board                  June 19, 2000
Donald C. Wegmiller

/s/ Dean Belbas           Director                               June 19, 2000
Dean Belbas

/s/ Seymour J. Mansfield  Director                               June 19, 2000
Seymour J. Mansfield

/s/ William C. Mattison   Director                               June 19, 2000
William C. Mattison

/s/ Whitney A. McFarlin   Director                               June 19, 2000
Whitney A. McFarlin

/s/ Rodney A. Young       Director                               June 19, 2000
Rodney A. Young
EXHIBIT INDEX

     4.1 Possis Medical,  Inc. 1999 Stock  Compensation  Plan  (incorporated  by
reference to the  registrant's  Definitive  Proxy  Statement  filed  November 8,
1999).

     5.1 Opinion of Dorsey & Whitney LLP.

     23.1 Consent of Deloitte & Touche LLP.

     23.2 Consent of Dorsey & Whitney LLP (included in Exhibit 5.1).
EXHIBIT 5.1

                      [Letterhead of Dorsey & Whitney LLP]

Possis Medical, Inc.
9055 Evergreen Boulevard N.W.
Minneapolis, Minnesota 55433

         Re:      Registration Statement on Form S-8

Ladies and Gentlemen:

     We have acted as counsel to Possis Medical,  Inc., a Minnesota  corporation
(the "Company"),  and have advised the Company in connection with a registration
statement  on Form S-8 relating to the sale or issuance by the Company from time
to time of up to  2,000,000  shares (the  "Shares") of common  stock,  par value
$.40, of the Company ("Common Stock") issuable under the 1999 Stock Compensation
Plan (the "Plan").

     We have examined such  documents and have reviewed such questions of law as
we have considered necessary and appropriate for the purposes of our opinion set
forth below.

     In rendering our opinion set forth below, we have assumed the  authenticity
of all documents submitted to us as originals, the genuineness of all signatures
and the  conformity to authentic  originals of all documents  submitted to us as
copies. We have also assumed the legal capacity for all purposes relevant hereto
of all  natural  persons  and,  with  respect to all  parties to  agreements  or
instruments  relevant  hereto other than the Company,  that such parties had the
requisite power and authority  (corporate or otherwise) to execute,  deliver and
perform such agreements or instruments, that such agreements or instruments have
been duly authorized by all requisite action (corporate or otherwise),  executed
and delivered by such parties and that such  agreements or  instruments  are the
valid,  binding and enforceable  obligations of such parties. As to questions of
fact material to our opinion,  we have relied upon  certificates  of officers of
the Company and of public officials.

     Based on the  foregoing,  we are of the  opinion  that the Shares have been
duly authorized and, upon issuance,  delivery and payment therefor in accordance
with the terms of the Plan,  and any  relevant  agreements  thereunder,  will be
validly issued, fully paid and nonassessable.

     Our  opinions  expressed  above  are  limited  to the laws of the  State of
Minnesota.

     We hereby  consent  to the  filing of this  opinion  as an  exhibit  to the
registration statement on Form S-8 of the Company relating to the Shares.

Dated:  June 19, 2000

                                           Very truly yours,

                                           /s/ Dorsey & Whitney LLP
EXHIBIT 23.1

INDEPENDENT AUDITORS' CONSENT

     We consent to the incorporation by reference in this Registration Statement
of  Possis  Medical,  Inc.  on Form S-8 of our  report  dated  August  31,  1999
(September 15, 1999 as to Note 10),  appearing in the Annual Report on Form 10-K
of Possis Medical, Inc. for the year ended July 31, 1999.

/s/ Deloitte & Touche LLP

Minneapolis, Minnesota
June 19, 2000